共 14 条
[3]
Non-antiarrhythmic medications for atrial fibrillation: From bench to clinical practice[J] . Maya Guglin,Marcos Garcia,Michael J. Yarnoz,Anne B. Curtis.Journal of Interventional Cardiac Electrophysiology . 2008 (2)
[4]
Angiotensin II Activates Signal Transducer and Activators of Transcription 3 via Rac1 in Atrial Myocytes and Fibroblasts: Implication for the Therapeutic Effect of Statin in Atrial Structural Remodeling[J] . Chia-Ti Tsai,Ling-Ping Lai,Kuan-Ting Kuo,Juey-Jen Hwang,Chia-Shan Hsieh,Kuan-Lih Hsu,Chuen-Den Tseng,Yung-Zu Tseng,Fu-Tien Chiang,Jiunn-Lee Lin.Circulation . 2008 (3)
[7]
Inflammation and atrial fibrillation: Is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation?[J] . Ri Bo Tang,Jian Zeng Dong,Xing Peng Liu,Chang Sheng Ma.Medical Hypotheses . 2006 (3)
[8]
ACE–inhibitor treatment attenuates atrialstructural remodeling in patients with lonechronic atrial fibrillation[J] . A. Boldt,A. Scholl,J. Garbade,M. E. Resetar,F. W. Mohr,J. F. Gummert,St. Dhein.Basic Research in Cardiology . 2006 (3)
[10]
Mice with Cardiac-Restricted Angiotensin-Converting Enzyme (ACE) Have Atrial Enlargement, Cardiac Arrhythmia, and Sudden Death[J] . Hong D. Xiao,Sebastien Fuchs,Duncan J. Campbell,William Lewis,Samuel C. Dudley,Vijaykumar S. Kasi,Brian D. Hoit,George Keshelava,Hui Zhao,Mario R. Capecchi,Kenneth E. Bernstein.The American Journal of Pathology . 2004 (3)